A share price of Exagen Inc [XGN] is currently trading at $8.45, up 14.34%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The XGN shares have gain 21.76% over the last week, with a monthly amount glided 20.71%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exagen Inc [NASDAQ: XGN] stock has seen the most recent analyst activity on July 23, 2025, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $12. Previously, KeyBanc Capital Markets downgraded its rating to Sector Weight on August 05, 2022. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $25 on April 15, 2021. KeyBanc Capital Markets initiated its recommendation with a Overweight and recommended $32 as its price target on November 10, 2020. BTIG Research started tracking with a Buy rating for this stock on October 08, 2020, and assigned it a price target of $18.
Exagen Inc experienced fluctuations in its stock price throughout the past year between $1.78 and $7.95. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Exagen Inc [NASDAQ: XGN] shares were valued at $8.45 at the most recent close of the market. An investor can expect a potential drop of -40.83% based on the average XGN price forecast.
Analyzing the XGN fundamentals
Trailing Twelve Months sales for Exagen Inc [NASDAQ:XGN] were 58.86M which represents 14.19% growth. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -0.24%, Pretax Profit Margin comes in at -0.29%, and Net Profit Margin reading is -0.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -1.36 and Total Capital is -0.29. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.83 points at the first support level, and at 7.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.93, and for the 2nd resistance point, it is at 9.42.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Exagen Inc [NASDAQ:XGN] is 4.95. As well, the Quick Ratio is 4.59, while the Cash Ratio is 2.92. Considering the valuation of this stock, the price to sales ratio is 3.14, the price to book ratio is 8.84.
Transactions by insiders
Recent insider trading involved NMSIC Co-Investment Fund, L.P., 10% Owner, that happened on Mar 25 ’25 when 0.35 million shares were sold. 10% Owner, NMSIC Co-Investment Fund, L.P. completed a deal on Nov 20 ’24 to sell 0.2 million shares. Meanwhile, Chief Financial Officer Black Jeffrey G. bought 22298.0 shares on Nov 15 ’24.
